| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | symporter activity | SLC17A2 SLC11A2 SLC17A3 SLC5A7 MFSD12 SLC17A5 SLC46A3 SLC5A6 SLC23A2 | 4.45e-08 | 150 | 96 | 9 | GO:0015293 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC17A2 SLC11A2 SLC17A3 ABCA12 ABCB5 SLC5A7 ABCC5 ABCA7 ABCA9 MFSD12 SLC17A5 SLC46A3 SLC5A6 SLC23A2 | 6.52e-08 | 477 | 96 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | SLC17A2 SLC11A2 SLC17A3 ABCA12 ABCB5 SLC5A7 ABCC5 ATP8B1 GRIN2A GRIN2B ABCA7 ABCA9 MFSD12 SLC39A13 CHRND SLC17A5 SLC46A3 SLC22A13 SLC5A6 SERINC3 SLC23A2 VDAC3 | 1.46e-07 | 1289 | 96 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC17A2 SLC11A2 SLC17A3 ABCA12 ABCB5 SLC5A7 ABCC5 GRIN2A GRIN2B ABCA7 ABCA9 MFSD12 SLC39A13 CHRND SLC17A5 SLC46A3 SLC22A13 SLC5A6 SERINC3 SLC23A2 VDAC3 | 1.48e-07 | 1180 | 96 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC17A3 ABCC5 GRIN2A GRIN2B MFSD12 SLC17A5 SLC22A13 SLC5A6 SERINC3 SLC23A2 | 1.47e-06 | 293 | 96 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.72e-06 | 119 | 96 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.73e-06 | 49 | 96 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | GRIN2A GRIN2B MFSD12 SLC17A5 SLC22A13 SLC5A6 SERINC3 SLC23A2 | 7.07e-06 | 207 | 96 | 8 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | GRIN2A GRIN2B MFSD12 SLC17A5 SLC22A13 SLC5A6 SERINC3 SLC23A2 | 7.33e-06 | 208 | 96 | 8 | GO:0005342 |
| GeneOntologyMolecularFunction | urate transmembrane transporter activity | 8.86e-06 | 9 | 96 | 3 | GO:0015143 | |
| GeneOntologyMolecularFunction | salt transmembrane transporter activity | 8.86e-06 | 9 | 96 | 3 | GO:1901702 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC17A2 SLC11A2 SLC17A3 SLC5A7 MFSD12 SLC17A5 SLC46A3 SLC5A6 SLC23A2 | 1.28e-05 | 296 | 96 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.44e-05 | 81 | 96 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 5.76e-05 | 16 | 96 | 3 | GO:0015562 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 6.84e-05 | 3 | 96 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | PRLHR OPN4 HTR2B ROR1 ROR2 CASR GRIN2A GRIN2B TAAR8 GABBR2 ITGAL ABCA7 CHRND ADRA1A PTPRA NRXN1 KIT SORL1 | 6.99e-05 | 1353 | 96 | 18 | GO:0004888 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC17A2 SLC11A2 SLC17A3 SLC5A7 GRIN2A GRIN2B SLC39A13 SLC46A3 SLC5A6 SLC23A2 | 8.03e-05 | 465 | 96 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC17A2 SLC11A2 SLC17A3 SLC5A7 GRIN2A GRIN2B SLC39A13 CHRND SLC17A5 SLC46A3 SLC5A6 SLC23A2 | 8.06e-05 | 664 | 96 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC17A2 SLC11A2 SLC17A3 SLC5A7 GRIN2A GRIN2B SLC39A13 CHRND SLC17A5 SLC46A3 SLC5A6 SLC23A2 VDAC3 | 1.07e-04 | 793 | 96 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.82e-04 | 109 | 96 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC17A2 SLC11A2 SLC17A3 SLC5A7 GRIN2A GRIN2B SLC39A13 SLC17A5 SLC46A3 SLC5A6 SLC23A2 | 2.11e-04 | 627 | 96 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC17A2 SLC11A2 SLC17A3 SLC5A7 ABCC5 GRIN2A GRIN2B SLC39A13 SLC17A5 SLC46A3 SLC5A6 SLC23A2 | 2.76e-04 | 758 | 96 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.23e-04 | 28 | 96 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | amino acid binding | 4.24e-04 | 73 | 96 | 4 | GO:0016597 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 4.73e-04 | 7 | 96 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 5.78e-04 | 34 | 96 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 6.26e-04 | 301 | 96 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 6.29e-04 | 8 | 96 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | copper ion transmembrane transporter activity | 6.29e-04 | 8 | 96 | 2 | GO:0005375 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 6.29e-04 | 8 | 96 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 6.29e-04 | 8 | 96 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 8.06e-04 | 9 | 96 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 1.01e-03 | 41 | 96 | 3 | GO:0008227 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.16e-03 | 43 | 96 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 1.24e-03 | 44 | 96 | 3 | GO:0046915 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.29e-03 | 441 | 96 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.38e-03 | 100 | 96 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.42e-03 | 171 | 96 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 1.46e-03 | 12 | 96 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 1.46e-03 | 12 | 96 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.49e-03 | 102 | 96 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.65e-03 | 105 | 96 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.69e-03 | 178 | 96 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | UDP-glucosyltransferase activity | 1.72e-03 | 13 | 96 | 2 | GO:0035251 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.90e-03 | 51 | 96 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | glutamate binding | 2.00e-03 | 14 | 96 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 2.31e-03 | 15 | 96 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | glucosidase activity | 2.31e-03 | 15 | 96 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.61e-03 | 57 | 96 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.63e-03 | 16 | 96 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | floppase activity | 2.63e-03 | 16 | 96 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 2.79e-03 | 614 | 96 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 2.97e-03 | 17 | 96 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 2.97e-03 | 17 | 96 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.97e-03 | 17 | 96 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.02e-03 | 60 | 96 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.17e-03 | 61 | 96 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | amide binding | 3.22e-03 | 299 | 96 | 6 | GO:0033218 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.53e-03 | 211 | 96 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.79e-03 | 65 | 96 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.79e-03 | 65 | 96 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 3.79e-03 | 65 | 96 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 4.11e-03 | 20 | 96 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | peptide binding | 4.35e-03 | 318 | 96 | 6 | GO:0042277 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 4.53e-03 | 21 | 96 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 4.96e-03 | 22 | 96 | 2 | GO:0051010 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 4.96e-03 | 22 | 96 | 2 | GO:0046527 | |
| GeneOntologyMolecularFunction | coreceptor activity | 5.05e-03 | 72 | 96 | 3 | GO:0015026 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 5.29e-03 | 145 | 96 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 5.66e-03 | 75 | 96 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 5.89e-03 | 24 | 96 | 2 | GO:0005315 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.89e-03 | 24 | 96 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 6.09e-03 | 77 | 96 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 6.38e-03 | 153 | 96 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 6.39e-03 | 25 | 96 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 7.42e-03 | 27 | 96 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 7.50e-03 | 83 | 96 | 3 | GO:0015101 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 8.00e-03 | 85 | 96 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 8.00e-03 | 85 | 96 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 9.37e-03 | 171 | 96 | 4 | GO:0015103 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.25e-06 | 183 | 96 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC17A2 SLC17A3 ABCC5 CASR ATP8B1 GRIN2B MFSD12 SLC17A5 SLC22A13 SLC5A6 SERINC3 SLC23A2 | 4.81e-06 | 515 | 96 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 1.15e-05 | 10 | 96 | 3 | GO:0097151 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC17A2 SLC11A2 HTR2B SLC17A3 ABCC5 CASR ATP8B1 GRIN2A GRIN2B SLC39A13 CHRND SLC17A5 ADRA1A SLC46A3 SLC5A6 SLC23A2 VDAC3 | 1.38e-05 | 1115 | 96 | 17 | GO:0034220 |
| GeneOntologyBiologicalProcess | urate transport | 1.57e-05 | 11 | 96 | 3 | GO:0015747 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 1.64e-05 | 240 | 96 | 8 | GO:0070374 | |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 2.09e-05 | 12 | 96 | 3 | GO:0098828 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | ABCC5 CASR ATP8B1 GRIN2B MFSD12 SLC17A5 SLC22A13 SLC5A6 SERINC3 SLC23A2 | 2.13e-05 | 410 | 96 | 10 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | ABCC5 CASR ATP8B1 GRIN2B MFSD12 SLC17A5 SLC22A13 SLC5A6 SERINC3 SLC23A2 | 2.22e-05 | 412 | 96 | 10 | GO:0015849 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 4.73e-05 | 43 | 96 | 4 | GO:0051968 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC17A2 SLC11A2 HTR2B SLC17A3 SLC5A7 ABCC5 CASR ATP8B1 GRIN2A GRIN2B SLC39A13 CHRND SLC17A5 ADRA1A SLC46A3 SLC5A6 SLC23A2 VDAC3 | 5.62e-05 | 1374 | 96 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 7.02e-05 | 92 | 96 | 5 | GO:0051966 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | SLC11A2 HTR2B PILRB ROR1 ROR2 MSH2 GRIN2A GRIN2B KHDC1 ADRA1A NRXN1 SPDYE3 CTSD KIT VAV1 | 7.77e-05 | 1028 | 96 | 15 | GO:0043085 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC17A2 SLC11A2 HTR2B SLC17A3 SLC5A7 ABCC5 CASR GRIN2A GRIN2B SLC39A13 CHRND SLC17A5 ADRA1A SLC46A3 SLC5A6 SLC23A2 | 8.23e-05 | 1157 | 96 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | neuromuscular process | 8.76e-05 | 225 | 96 | 7 | GO:0050905 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | HTR2B ROR2 SLC5A7 GRIN2A GRIN2B GABBR2 CHRND ADRA1A PTPRA NRXN1 FRRS1L IGSF9B KIT VDAC3 | 1.01e-04 | 931 | 96 | 14 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | HTR2B ROR2 SLC5A7 GRIN2A GRIN2B GABBR2 CHRND ADRA1A PTPRA NRXN1 FRRS1L IGSF9B KIT VDAC3 | 1.01e-04 | 931 | 96 | 14 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | HTR2B ROR2 SLC5A7 GRIN2A GRIN2B GABBR2 CHRND ADRA1A PTPRA NRXN1 FRRS1L IGSF9B KIT VDAC3 | 1.10e-04 | 939 | 96 | 14 | GO:0099537 |
| GeneOntologyBiologicalProcess | amide metabolic process | 1.34e-04 | 511 | 96 | 10 | GO:0043603 | |
| GeneOntologyBiologicalProcess | vitamin transmembrane transport | 1.62e-04 | 23 | 96 | 3 | GO:0035461 | |
| GeneOntologyBiologicalProcess | synaptic signaling | HTR2B ROR2 SLC5A7 GRIN2A GRIN2B GABBR2 CHRND ADRA1A PTPRA NRXN1 FRRS1L IGSF9B KIT VDAC3 | 1.65e-04 | 976 | 96 | 14 | GO:0099536 |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 1.74e-04 | 176 | 96 | 6 | GO:0006665 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC17A2 SLC11A2 HTR2B SLC17A3 SLC5A7 ABCC5 CASR GRIN2A GRIN2B SLC39A13 ADRA1A SLC46A3 SLC5A6 SLC23A2 | 2.12e-04 | 1000 | 96 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | neuron-glial cell signaling | 2.12e-04 | 5 | 96 | 2 | GO:0150099 | |
| GeneOntologyBiologicalProcess | insulin receptor recycling | 2.12e-04 | 5 | 96 | 2 | GO:0038020 | |
| GeneOntologyBiologicalProcess | protein localization to paranode region of axon | 2.12e-04 | 5 | 96 | 2 | GO:0002175 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 2.26e-04 | 64 | 96 | 4 | GO:0042908 | |
| GeneOntologyBiologicalProcess | behavior | PRLHR OPN4 SLC11A2 HTR2B CASR GRIN2A GRIN2B ABCA7 NRXN1 CLN6 KIT GAA VDAC3 | 2.44e-04 | 891 | 96 | 13 | GO:0007610 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC17A2 SLC11A2 HTR2B SLC17A3 ABCC5 CASR GRIN2A GRIN2B SLC39A13 SLC17A5 ADRA1A SLC46A3 SLC5A6 SLC23A2 | 2.52e-04 | 1017 | 96 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 2.64e-04 | 27 | 96 | 3 | GO:0010875 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 2.64e-04 | 27 | 96 | 3 | GO:0060080 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | SLC11A2 HTR2B PILRB ROR1 ROR2 CASR MSH2 GRIN2A GRIN2B KHDC1 ADRA1A NRXN1 SPDYE3 LRP1 CTSD KIT VAV1 | 2.98e-04 | 1430 | 96 | 17 | GO:0044093 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC17A2 SLC11A2 HTR2B SLC17A3 ABCC5 GRIN2A GRIN2B SLC39A13 SLC17A5 ADRA1A SLC46A3 SLC5A6 SLC23A2 | 3.40e-04 | 922 | 96 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | glycosphingolipid metabolic process | 3.75e-04 | 73 | 96 | 4 | GO:0006687 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 3.82e-04 | 132 | 96 | 5 | GO:0035249 | |
| GeneOntologyBiologicalProcess | neuromuscular process controlling balance | 3.95e-04 | 74 | 96 | 4 | GO:0050885 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC17A2 SLC11A2 HTR2B SLC17A3 ABCC5 GRIN2A GRIN2B SLC39A13 SLC17A5 ADRA1A SLC46A3 SLC5A6 SLC23A2 | 4.17e-04 | 942 | 96 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | protein localization to membrane | EMC6 ABCA12 GRIN2A GRIN2B ITGAL NRXN1 FRRS1L TMEM147 LRP1 HECTD1 SORL1 | 4.34e-04 | 705 | 96 | 11 | GO:0072657 |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 4.35e-04 | 385 | 96 | 8 | GO:0070372 | |
| GeneOntologyBiologicalProcess | learning | 4.72e-04 | 212 | 96 | 6 | GO:0007612 | |
| GeneOntologyBiologicalProcess | receptor metabolic process | 5.84e-04 | 82 | 96 | 4 | GO:0043112 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid-beta clearance | 5.89e-04 | 8 | 96 | 2 | GO:1900223 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 5.89e-04 | 8 | 96 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | paranodal junction assembly | 5.89e-04 | 8 | 96 | 2 | GO:0030913 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 6.07e-04 | 405 | 96 | 8 | GO:0033674 | |
| GeneOntologyBiologicalProcess | receptor clustering | 6.11e-04 | 83 | 96 | 4 | GO:0043113 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 6.24e-04 | 147 | 96 | 5 | GO:0099565 | |
| GeneOntologyBiologicalProcess | visual behavior | 6.99e-04 | 86 | 96 | 4 | GO:0007632 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 7.08e-04 | 229 | 96 | 6 | GO:0006643 | |
| GeneOntologyBiologicalProcess | positive regulation of cysteine-type endopeptidase activity | 7.26e-04 | 152 | 96 | 5 | GO:2001056 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 7.45e-04 | 418 | 96 | 8 | GO:0070371 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 7.47e-04 | 153 | 96 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | copper ion transmembrane transport | 7.56e-04 | 9 | 96 | 2 | GO:0035434 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 8.52e-04 | 40 | 96 | 3 | GO:0048169 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 8.52e-04 | 40 | 96 | 3 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 8.52e-04 | 40 | 96 | 3 | GO:0032376 | |
| GeneOntologyBiologicalProcess | startle response | 9.16e-04 | 41 | 96 | 3 | GO:0001964 | |
| GeneOntologyBiologicalProcess | intestine smooth muscle contraction | 9.42e-04 | 10 | 96 | 2 | GO:0014827 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 9.66e-04 | 162 | 96 | 5 | GO:0015748 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 9.93e-04 | 163 | 96 | 5 | GO:1905039 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 1.05e-03 | 43 | 96 | 3 | GO:2000463 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.11e-03 | 167 | 96 | 5 | GO:1903825 | |
| GeneOntologyBiologicalProcess | protein localization to axon | 1.15e-03 | 11 | 96 | 2 | GO:0099612 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.18e-03 | 559 | 96 | 9 | GO:0042391 | |
| GeneOntologyBiologicalProcess | localization within membrane | EMC6 ABCA12 GRIN2A GRIN2B ITGAL NRXN1 FRRS1L TMEM147 LRP1 HECTD1 SORL1 | 1.20e-03 | 798 | 96 | 11 | GO:0051668 |
| GeneOntologyCellularComponent | presynapse | ROR1 CNTNAP1 SLC5A7 DAO CASR GRIN2A GRIN2B GABBR2 SLC17A5 ADRA1A NRXN1 LGI3 EGFLAM CTSD VDAC3 | 1.37e-05 | 886 | 97 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | receptor complex | HTR2B ROR1 ROR2 GRIN2A GRIN2B GABBR2 ITGAL CHRND PTPRA LRP1 ALCAM KIT | 1.57e-05 | 581 | 97 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC17A2 SLC11A2 SLC17A3 SLC5A7 ABCC5 CASR ATP8B1 ABCA7 SLC22A13 SLC5A6 SLC23A2 | 1.60e-05 | 487 | 97 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | SLC17A2 SLC11A2 SLC17A3 SLC5A7 ABCC5 CASR ATP8B1 ABCA7 SLC22A13 SLC5A6 LRP1 SLC23A2 | 1.90e-05 | 592 | 97 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SLC11A2 ABCA12 ROR2 SLC5A7 ABCC5 GRIN2A GRIN2B ITGAL ABCA7 MFSD12 SLC39A13 PIK3R4 SLC17A5 LRP1 CTSD GAA SORL1 | 9.88e-05 | 1307 | 97 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | SLC11A2 ABCA12 ROR2 SLC5A7 ABCC5 GRIN2A GRIN2B ITGAL ABCA7 MFSD12 SLC39A13 PIK3R4 SLC17A5 LRP1 CTSD GAA SORL1 | 1.17e-04 | 1325 | 97 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | neuronal cell body | OPN4 HTR2B ROR2 SRD5A2 SLC5A7 CASR GRIN2B NRXN1 LRP1 ASTN2 IGSF9B ALCAM SORL1 | 1.26e-04 | 835 | 97 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | axon | OPN4 ROR1 CNTNAP1 SLC5A7 CASR GRIN2A GRIN2B CLDN11 NRXN1 LGI3 LRP1 IGSF9 ALCAM | 2.38e-04 | 891 | 97 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | cell body | OPN4 HTR2B ROR2 SRD5A2 SLC5A7 CASR GRIN2B NRXN1 LRP1 ASTN2 IGSF9B ALCAM SORL1 | 3.56e-04 | 929 | 97 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | synaptic membrane | SLC5A7 GRIN2A GRIN2B GABBR2 CHRND ADRA1A PTPRA NRXN1 LRP1 IGSF9B | 3.76e-04 | 583 | 97 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | basal part of cell | 3.78e-04 | 378 | 97 | 8 | GO:0045178 | |
| GeneOntologyCellularComponent | inhibitory synapse | 3.96e-04 | 31 | 97 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.10e-04 | 141 | 97 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | somatodendritic compartment | OPN4 HTR2B ROR2 SRD5A2 SLC5A7 CASR GRIN2A GRIN2B NRXN1 LRP1 ASTN2 IGSF9 IGSF9B ALCAM SORL1 | 5.18e-04 | 1228 | 97 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | cell surface | SLC11A2 ROR1 ROR2 CASR GRIN2A GRIN2B ITGAL ABCA7 NRXN1 LRP1 CORIN ALCAM KIT SORL1 | 5.96e-04 | 1111 | 97 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | brush border membrane | 6.05e-04 | 83 | 97 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | brush border | 7.16e-04 | 152 | 97 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 7.51e-04 | 9 | 97 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | EMC6 SLC17A3 TECR SRD5A2 MMP23B GRIN2A GRIN2B SLC39A13 LCTL FRRS1L TMEM147 CLN6 UGT8 FITM1 SORL1 | 8.81e-04 | 1293 | 97 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | EMC6 SLC17A3 TECR SRD5A2 MMP23B GRIN2A GRIN2B SLC39A13 LCTL FRRS1L TMEM147 CLN6 UGT8 FITM1 SORL1 | 9.23e-04 | 1299 | 97 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | endosome | SLC11A2 SLC5A7 ABCC5 GRIN2B BIRC6 ABCA7 MFSD12 GPR107 PIK3R4 LRP1 CLN6 ASTN2 CTSD SORL1 | 9.63e-04 | 1167 | 97 | 14 | GO:0005768 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.01e-03 | 164 | 97 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | EMC6 SLC17A3 TECR SRD5A2 MMP23B GRIN2A GRIN2B SLC39A13 LCTL FRRS1L TMEM147 CLN6 UGT8 FITM1 SORL1 | 1.14e-03 | 1327 | 97 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | early endosome | 1.79e-03 | 481 | 97 | 8 | GO:0005769 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.85e-03 | 277 | 97 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | synaptic vesicle | 2.76e-03 | 300 | 97 | 6 | GO:0008021 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.80e-03 | 405 | 97 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | transport vesicle | 2.87e-03 | 519 | 97 | 8 | GO:0030133 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.78e-03 | 320 | 97 | 6 | GO:0016323 | |
| GeneOntologyCellularComponent | exocytic vesicle | 3.78e-03 | 320 | 97 | 6 | GO:0070382 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.85e-03 | 223 | 97 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ROR2 CNTNAP1 CASR GRIN2A GRIN2B GABBR2 SLC17A5 ADRA1A NRXN1 LRP1 | 4.62e-03 | 817 | 97 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 4.97e-03 | 237 | 97 | 5 | GO:0030136 | |
| GeneOntologyCellularComponent | late endosome | 5.67e-03 | 348 | 97 | 6 | GO:0005770 | |
| GeneOntologyCellularComponent | lysosomal membrane | 5.74e-03 | 462 | 97 | 7 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 5.74e-03 | 462 | 97 | 7 | GO:0098852 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 5.82e-03 | 350 | 97 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | basal plasma membrane | 6.15e-03 | 354 | 97 | 6 | GO:0009925 | |
| GeneOntologyCellularComponent | dendrite | OPN4 HTR2B ROR2 SLC5A7 GRIN2A GRIN2B LRP1 IGSF9 IGSF9B ALCAM | 6.46e-03 | 858 | 97 | 10 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | OPN4 HTR2B ROR2 SLC5A7 GRIN2A GRIN2B LRP1 IGSF9 IGSF9B ALCAM | 6.57e-03 | 860 | 97 | 10 | GO:0097447 |
| Domain | MFS_1 | 2.46e-06 | 77 | 94 | 6 | PF07690 | |
| Domain | MFS | 2.46e-06 | 77 | 94 | 6 | IPR011701 | |
| Domain | ABC_tran | 4.19e-06 | 48 | 94 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.19e-06 | 48 | 94 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 4.64e-06 | 49 | 94 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 5.14e-06 | 50 | 94 | 5 | IPR003439 | |
| Domain | MFS | 1.75e-05 | 108 | 94 | 6 | PS50850 | |
| Domain | Tyr_kinase_rcpt_ROR | 2.51e-05 | 2 | 94 | 2 | IPR016247 | |
| Domain | ABC_A | 2.63e-05 | 12 | 94 | 3 | IPR026082 | |
| Domain | ANF_lig-bd_rcpt | 3.50e-05 | 37 | 94 | 4 | IPR001828 | |
| Domain | ANF_receptor | 3.50e-05 | 37 | 94 | 4 | PF01094 | |
| Domain | Peripla_BP_I | 4.32e-05 | 39 | 94 | 4 | IPR028082 | |
| Domain | ABC_transporter_CS | 5.82e-05 | 42 | 94 | 4 | IPR017871 | |
| Domain | MFS_dom | 5.92e-05 | 134 | 94 | 6 | IPR020846 | |
| Domain | NMDAR2_C | 7.49e-05 | 3 | 94 | 2 | PF10565 | |
| Domain | NMDAR2_C | 7.49e-05 | 3 | 94 | 2 | IPR018884 | |
| Domain | - | PILRB PILRA ROR1 ROR2 MMP23B ASTN2 IGSF9 EGFLAM IGSF9B ALCAM KIT SORL1 | 1.21e-04 | 663 | 94 | 12 | 2.60.40.10 |
| Domain | Ig-like_fold | PILRB PILRA ROR1 ROR2 MMP23B ASTN2 IGSF9 EGFLAM IGSF9B ALCAM KIT SORL1 | 2.17e-04 | 706 | 94 | 12 | IPR013783 |
| Domain | Frizzled_dom | 2.31e-04 | 24 | 94 | 3 | IPR020067 | |
| Domain | FZ | 2.31e-04 | 24 | 94 | 3 | PS50038 | |
| Domain | Fz | 2.31e-04 | 24 | 94 | 3 | PF01392 | |
| Domain | 3-oxo-5_a-steroid_4-DH_C | 2.48e-04 | 5 | 94 | 2 | IPR001104 | |
| Domain | Steroid_dh | 2.48e-04 | 5 | 94 | 2 | PF02544 | |
| Domain | TDE1/TMS | 2.48e-04 | 5 | 94 | 2 | IPR005016 | |
| Domain | S5A_REDUCTASE | 2.48e-04 | 5 | 94 | 2 | PS50244 | |
| Domain | Serinc | 2.48e-04 | 5 | 94 | 2 | PF03348 | |
| Domain | 7TM_GPCR_Srsx | 2.55e-04 | 112 | 94 | 5 | SM01381 | |
| Domain | IG | 2.70e-04 | 421 | 94 | 9 | SM00409 | |
| Domain | Ig_sub | 2.70e-04 | 421 | 94 | 9 | IPR003599 | |
| Domain | AAA+_ATPase | 8.04e-04 | 144 | 94 | 5 | IPR003593 | |
| Domain | AAA | 8.04e-04 | 144 | 94 | 5 | SM00382 | |
| Domain | IG_LIKE | 8.20e-04 | 491 | 94 | 9 | PS50835 | |
| Domain | LAM_G_DOMAIN | 9.17e-04 | 38 | 94 | 3 | PS50025 | |
| Domain | Ig-like_dom | 9.72e-04 | 503 | 94 | 9 | IPR007110 | |
| Domain | TyrKc | 1.02e-03 | 88 | 94 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.02e-03 | 88 | 94 | 4 | IPR020635 | |
| Domain | LDLR_class-A_CS | 1.07e-03 | 40 | 94 | 3 | IPR023415 | |
| Domain | Laminin_G_2 | 1.07e-03 | 40 | 94 | 3 | PF02210 | |
| Domain | CAP_GLY | 1.10e-03 | 10 | 94 | 2 | PF01302 | |
| Domain | CAP_GLY_1 | 1.10e-03 | 10 | 94 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 1.10e-03 | 10 | 94 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 1.10e-03 | 10 | 94 | 2 | IPR000938 | |
| Domain | CAP_GLY | 1.10e-03 | 10 | 94 | 2 | SM01052 | |
| Domain | - | 1.10e-03 | 10 | 94 | 2 | 2.30.30.190 | |
| Domain | IGc2 | 1.21e-03 | 235 | 94 | 6 | SM00408 | |
| Domain | EGF_3 | 1.21e-03 | 235 | 94 | 6 | PS50026 | |
| Domain | Ig_sub2 | 1.21e-03 | 235 | 94 | 6 | IPR003598 | |
| Domain | NA_SOLUT_SYMP_1 | 1.34e-03 | 11 | 94 | 2 | PS00456 | |
| Domain | LamG | 1.41e-03 | 44 | 94 | 3 | SM00282 | |
| Domain | PROTEIN_KINASE_TYR | 1.46e-03 | 97 | 94 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.46e-03 | 97 | 94 | 4 | IPR008266 | |
| Domain | Ldl_recept_a | 1.50e-03 | 45 | 94 | 3 | PF00057 | |
| Domain | NA_SOLUT_SYMP_2 | 1.60e-03 | 12 | 94 | 2 | PS00457 | |
| Domain | SSF | 1.60e-03 | 12 | 94 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 1.60e-03 | 12 | 94 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 1.60e-03 | 12 | 94 | 2 | PS50283 | |
| Domain | Quinoprot_gluc/sorb_DH | 1.60e-03 | 12 | 94 | 2 | IPR011041 | |
| Domain | - | 1.60e-03 | 46 | 94 | 3 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.60e-03 | 46 | 94 | 3 | IPR011042 | |
| Domain | LDLRA_1 | 1.81e-03 | 48 | 94 | 3 | PS01209 | |
| Domain | LDLRA_2 | 1.92e-03 | 49 | 94 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.92e-03 | 49 | 94 | 3 | IPR002172 | |
| Domain | LDLa | 1.92e-03 | 49 | 94 | 3 | SM00192 | |
| Domain | Ldl_recept_b | 2.19e-03 | 14 | 94 | 2 | PF00058 | |
| Domain | LDLRB | 2.19e-03 | 14 | 94 | 2 | PS51120 | |
| Domain | GPCR_3_CS | 2.19e-03 | 14 | 94 | 2 | IPR017979 | |
| Domain | Neurexin-like | 2.19e-03 | 14 | 94 | 2 | IPR003585 | |
| Domain | 4.1m | 2.19e-03 | 14 | 94 | 2 | SM00294 | |
| Domain | EGF_2 | 2.21e-03 | 265 | 94 | 6 | PS01186 | |
| Domain | FN3 | 2.43e-03 | 185 | 94 | 5 | SM00060 | |
| Domain | LY | 2.52e-03 | 15 | 94 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.52e-03 | 15 | 94 | 2 | IPR000033 | |
| Domain | Laminin_G | 3.12e-03 | 58 | 94 | 3 | IPR001791 | |
| Domain | Kringle | 3.24e-03 | 17 | 94 | 2 | IPR000001 | |
| Domain | Gal_mutarotase_SF_dom | 3.24e-03 | 17 | 94 | 2 | IPR011013 | |
| Domain | Kringle_CS | 3.24e-03 | 17 | 94 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 3.24e-03 | 17 | 94 | 2 | PS50070 | |
| Domain | Kringle | 3.24e-03 | 17 | 94 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 3.24e-03 | 17 | 94 | 2 | PS00021 | |
| Domain | KR | 3.24e-03 | 17 | 94 | 2 | SM00130 | |
| Domain | FN3 | 3.33e-03 | 199 | 94 | 5 | PS50853 | |
| Domain | Iontro_rcpt | 3.64e-03 | 18 | 94 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 3.64e-03 | 18 | 94 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 3.64e-03 | 18 | 94 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 3.64e-03 | 18 | 94 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 3.64e-03 | 18 | 94 | 2 | SM00918 | |
| Domain | Lig_chan | 3.64e-03 | 18 | 94 | 2 | PF00060 | |
| Domain | PBPe | 3.64e-03 | 18 | 94 | 2 | SM00079 | |
| Domain | EGF | 3.77e-03 | 126 | 94 | 4 | PF00008 | |
| Domain | Pkinase_Tyr | 4.10e-03 | 129 | 94 | 4 | PF07714 | |
| Domain | FN3_dom | 4.10e-03 | 209 | 94 | 5 | IPR003961 | |
| Domain | GPCR_3 | 4.95e-03 | 21 | 94 | 2 | IPR000337 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.01e-06 | 44 | 73 | 5 | M11911 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 5.80e-05 | 15 | 73 | 3 | M47691 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 7.87e-05 | 272 | 73 | 8 | M13380 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 8.60e-05 | 17 | 73 | 3 | MM14552 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 1.03e-04 | 18 | 73 | 3 | M48098 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.03e-04 | 18 | 73 | 3 | M47761 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.03e-04 | 18 | 73 | 3 | M524 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 1.22e-04 | 19 | 73 | 3 | M47677 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.59e-04 | 99 | 73 | 5 | MM14986 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.91e-04 | 103 | 73 | 5 | M758 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 2.62e-04 | 5 | 73 | 2 | M47667 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC11A2 SLC17A3 ABCA12 ABCB5 SLC5A7 ABCC5 ATP8B1 ABCA7 ABCA9 SLC17A5 SLC5A6 VDAC3 | 3.66e-04 | 736 | 73 | 12 | M27287 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 3.91e-04 | 6 | 73 | 2 | M47668 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 6.01e-04 | 367 | 73 | 8 | M48346 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 6.23e-04 | 133 | 73 | 5 | M16476 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 6.50e-04 | 33 | 73 | 3 | M39875 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC11A2 SLC17A3 ABCA12 ABCB5 SLC5A7 ABCC5 ATP8B1 ABCA7 ABCA9 SLC17A5 SLC5A6 | 7.12e-04 | 681 | 73 | 11 | MM14985 |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 9.30e-04 | 9 | 73 | 2 | M27959 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 9.30e-04 | 9 | 73 | 2 | MM15707 | |
| Pubmed | Negative regulation of DSS-induced experimental colitis by PILRα. | 2.10e-08 | 3 | 97 | 3 | 25710489 | |
| Pubmed | 1.73e-07 | 300 | 97 | 9 | 19086053 | ||
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 16899073 | ||
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 12676993 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EMC6 NEMP1 ROR2 CNTNAP1 ABCA7 SLC39A13 GPR107 SLC5A6 LRP1 CLN6 UGT8 CERCAM ALCAM CTSD HECTD1 SORL1 | 2.12e-07 | 1201 | 97 | 16 | 35696571 |
| Pubmed | 4.00e-07 | 22 | 97 | 4 | 8894702 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | HTR2B CNTNAP1 GABBR2 ABCA7 MFSD12 SLC39A13 ADRA1A PTPRA SLC5A6 UGT8 SERINC3 ASTN2 | 5.76e-07 | 697 | 97 | 12 | 28298427 |
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 23267846 | ||
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 19036954 | ||
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 23760271 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 17360663 | ||
| Pubmed | AARS1 CNTNAP1 HECTD4 ABCC5 GRIN2B HNRNPUL1 CLIP4 PIK3R4 PTPRA RSPH1 LGI3 LRP1 CERCAM ASTN2 HECTD1 | 2.72e-06 | 1285 | 97 | 15 | 35914814 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 5.85e-06 | 91 | 97 | 5 | 28558017 | |
| Pubmed | 6.95e-06 | 164 | 97 | 6 | 32409323 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 25131300 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34763666 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12616499 | ||
| Pubmed | Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. | 7.70e-06 | 2 | 97 | 2 | 20921396 | |
| Pubmed | Linkage of shambling with sex in linkage group VII of the mouse. | 7.70e-06 | 2 | 97 | 2 | 5661165 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27199241 | ||
| Pubmed | The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. | 7.70e-06 | 2 | 97 | 2 | 16901514 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20696923 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23618906 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 19474217 | ||
| Pubmed | Importance of the GluN2B carboxy-terminal domain for enhancement of social memories. | 7.70e-06 | 2 | 97 | 2 | 26179233 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20826454 | ||
| Pubmed | Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. | 7.70e-06 | 2 | 97 | 2 | 16033900 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 38214768 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 21503117 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 18372311 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 32247039 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11713269 | ||
| Pubmed | D-amino acid oxidase knockdown in the mouse cerebellum reduces NR2A mRNA. | 7.70e-06 | 2 | 97 | 2 | 20828614 | |
| Pubmed | PILRα and PILRβ have a siglec fold and provide the basis of binding to sialic acid. | 7.70e-06 | 2 | 97 | 2 | 24843130 | |
| Pubmed | Separate functional properties of NMDARs regulate distinct aspects of spatial cognition. | 7.70e-06 | 2 | 97 | 2 | 29764972 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27605622 | ||
| Pubmed | The Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation. | 7.70e-06 | 2 | 97 | 2 | 34155901 | |
| Pubmed | Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function. | 7.70e-06 | 2 | 97 | 2 | 33043365 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30355491 | ||
| Pubmed | Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies. | 7.70e-06 | 2 | 97 | 2 | 22988987 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12127670 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20890276 | ||
| Pubmed | FUT2 inhibits the EMT and metastasis of colorectal cancer by increasing LRP1 fucosylation. | 7.70e-06 | 2 | 97 | 2 | 36973740 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 16045501 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27915379 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 37430307 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 10231392 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 32179753 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 16944113 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 38587578 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 9822733 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12898527 | ||
| Pubmed | NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. | 7.70e-06 | 2 | 97 | 2 | 15742215 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20686018 | ||
| Pubmed | Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. | 7.70e-06 | 2 | 97 | 2 | 11429290 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22081071 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 37657442 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 38813758 | ||
| Pubmed | Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease. | 7.70e-06 | 2 | 97 | 2 | 38731978 | |
| Pubmed | LRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype. | 7.70e-06 | 2 | 97 | 2 | 23866919 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 33443215 | ||
| Pubmed | A novel family of cell surface receptors with tyrosine kinase-like domain. | 7.70e-06 | 2 | 97 | 2 | 1334494 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30269991 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 31498792 | ||
| Pubmed | Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons. | 7.70e-06 | 2 | 97 | 2 | 32191258 | |
| Pubmed | Distinct roles of GRIN2A and GRIN2B variants in neurological conditions. | 7.70e-06 | 2 | 97 | 2 | 31807283 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 18988802 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26500840 | ||
| Pubmed | Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2. | 7.70e-06 | 2 | 97 | 2 | 15654020 | |
| Pubmed | Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains. | 7.70e-06 | 2 | 97 | 2 | 25029443 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27015584 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 19806658 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22142193 | ||
| Pubmed | Identification and characterization of stem cells in prepubertal spermatogenesis in mice. | 7.70e-06 | 2 | 97 | 2 | 12781694 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23142774 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 33976221 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22334046 | ||
| Pubmed | Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. | 7.70e-06 | 2 | 97 | 2 | 11455430 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20065029 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26515598 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34197904 | ||
| Pubmed | Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. | 7.70e-06 | 2 | 97 | 2 | 16157280 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34830255 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17942912 | ||
| Pubmed | NMDA Receptor C-Terminal Domain Signalling in Development, Maturity, and Disease. | 7.70e-06 | 2 | 97 | 2 | 36232696 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24935926 | ||
| Pubmed | Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors. | 7.70e-06 | 2 | 97 | 2 | 22306487 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26862065 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 36038077 | ||
| Pubmed | Evolution of GluN2A/B cytoplasmic domains diversified vertebrate synaptic plasticity and behavior. | 7.70e-06 | 2 | 97 | 2 | 23201971 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11719203 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20573830 | ||
| Pubmed | ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. | 7.70e-06 | 2 | 97 | 2 | 29395309 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 16266783 | ||
| Pubmed | Monocyte infiltration into obese and fibrilized tissues is regulated by PILRα. | 7.70e-06 | 2 | 97 | 2 | 26840635 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27839871 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22187052 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17569088 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24104062 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11530236 | ||
| Interaction | BTNL2 interactions | 8.72e-06 | 155 | 95 | 7 | int:BTNL2 | |
| Interaction | NETO1 interactions | 1.63e-05 | 11 | 95 | 3 | int:NETO1 | |
| Cytoband | 7q22.1 | 1.01e-04 | 113 | 97 | 4 | 7q22.1 | |
| Cytoband | 2p23 | 5.89e-04 | 17 | 97 | 2 | 2p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 1.23e-03 | 219 | 97 | 4 | chr7q22 | |
| Cytoband | 6q13 | 3.11e-03 | 39 | 97 | 2 | 6q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 3.95e-03 | 149 | 97 | 3 | chr2p23 | |
| GeneFamily | Solute carriers | SLC17A2 SLC11A2 SLC17A3 SLC5A7 SLC39A13 SLC17A5 SLC46A3 SLC22A13 SLC5A6 SLC23A2 | 2.38e-06 | 395 | 69 | 10 | 752 |
| GeneFamily | ATP binding cassette subfamily A | 1.88e-05 | 14 | 69 | 3 | 805 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 2.98e-04 | 7 | 69 | 2 | 1201 | |
| GeneFamily | Fibronectin type III domain containing | 3.63e-04 | 160 | 69 | 5 | 555 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.75e-04 | 40 | 69 | 3 | 321 | |
| GeneFamily | Immunoglobulin like domain containing | 8.51e-04 | 193 | 69 | 5 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.34e-03 | 161 | 69 | 4 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.49e-03 | 163 | 69 | 4 | 590 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 174 | 97 | 6 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 174 | 97 | 6 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 191 | 97 | 6 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 192 | 97 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.50e-06 | 196 | 97 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 4.91e-06 | 199 | 97 | 6 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.05e-06 | 200 | 97 | 6 | a2548b0c77ba1616638351b111cce2fe0cacaa95 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.05e-06 | 200 | 97 | 6 | e4a499b69554f78161c2c47199da77c201910e73 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.05e-06 | 200 | 97 | 6 | d64895354218ebd0217011bae0967a6883bbd1cd | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.34e-06 | 115 | 97 | 5 | 15b2c11225802cc15c01165d84a755432f02d82f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.57e-06 | 116 | 97 | 5 | c19974992b315fb873664fe3f5077ff8e907e30c | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.31e-06 | 119 | 97 | 5 | ec3af1253f03b3ec403f73243237acf08ad56789 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 139 | 97 | 5 | 96e6fed23e7a69f678f85e8e2fe77a7491586b4b | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.59e-05 | 144 | 97 | 5 | 9d6133558728fa148050eb4f0be33756d71310b0 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.76e-05 | 147 | 97 | 5 | a21b63d0d3aec9ffadf3fac833a0a24da58a95bf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-05 | 148 | 97 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 152 | 97 | 5 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.13e-05 | 153 | 97 | 5 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 154 | 97 | 5 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 158 | 97 | 5 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 158 | 97 | 5 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-05 | 160 | 97 | 5 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Tmem2_(Pdgfa)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.69e-05 | 79 | 97 | 4 | cd182dbc8d0ccc2406e78c9ba71476c1f463359b | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Tmem2_(Pdgfa)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.69e-05 | 79 | 97 | 4 | bcb9181d7de7a385b890523299f8290836aa536e | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-05 | 162 | 97 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.06e-05 | 165 | 97 | 5 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 171 | 97 | 5 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 171 | 97 | 5 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 173 | 97 | 5 | 9ba55e21d1037ec3150d77895e52f0b051df65da | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.84e-05 | 173 | 97 | 5 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-05 | 174 | 97 | 5 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.06e-05 | 175 | 97 | 5 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.06e-05 | 175 | 97 | 5 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-05 | 175 | 97 | 5 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 175 | 97 | 5 | 0992de1c7bffcb6890584357a7a0a8955927da6c | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-05 | 176 | 97 | 5 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-05 | 177 | 97 | 5 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.28e-05 | 177 | 97 | 5 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_LGI2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.52e-05 | 179 | 97 | 5 | 8dd10e3a9ab39d9a770cecac6e2ed3676b79e906 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.52e-05 | 179 | 97 | 5 | d96741c5c551e36421b2ad938072ab7d506c3835 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-05 | 180 | 97 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 182 | 97 | 5 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-05 | 184 | 97 | 5 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 185 | 97 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 185 | 97 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | Mild-NK|World / Disease group and Cell class | 5.28e-05 | 185 | 97 | 5 | 0565b7c464e1a09e596f5a0b363d2dc9b55c3c50 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 186 | 97 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 5.42e-05 | 186 | 97 | 5 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.42e-05 | 186 | 97 | 5 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.56e-05 | 187 | 97 | 5 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.56e-05 | 95 | 97 | 4 | 0ac6cba7e0ed6083f777287f39a871461fa1bca4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 189 | 97 | 5 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 190 | 97 | 5 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 190 | 97 | 5 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-05 | 191 | 97 | 5 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-05 | 191 | 97 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-05 | 191 | 97 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | MS-NK-|MS / Condition, Cell_class and T cell subcluster | 6.30e-05 | 192 | 97 | 5 | f97f5f8226f5c65ca93072ef35d753231bee2490 | |
| ToppCell | MS-NK|MS / Condition, Cell_class and T cell subcluster | 6.30e-05 | 192 | 97 | 5 | f44f5dd30db169fdd16c9d706d17ad44907a17af | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 192 | 97 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.46e-05 | 193 | 97 | 5 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-05 | 193 | 97 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-05 | 193 | 97 | 5 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 97 | 5 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 195 | 97 | 5 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.78e-05 | 195 | 97 | 5 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 195 | 97 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-05 | 195 | 97 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 196 | 97 | 5 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 196 | 97 | 5 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 196 | 97 | 5 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 7.11e-05 | 197 | 97 | 5 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-PNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.11e-05 | 197 | 97 | 5 | 10e72b425a2bcba35e63a5b074d3dedcd49a762e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.28e-05 | 198 | 97 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.28e-05 | 198 | 97 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.28e-05 | 198 | 97 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.28e-05 | 198 | 97 | 5 | 3b4611c9ee4d42e042a29ddb4580a95938d87d65 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.28e-05 | 198 | 97 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.28e-05 | 198 | 97 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 7.28e-05 | 198 | 97 | 5 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 7.46e-05 | 199 | 97 | 5 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.46e-05 | 199 | 97 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 7.46e-05 | 199 | 97 | 5 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | mild_COVID-19-NK|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.46e-05 | 199 | 97 | 5 | 4854f25ee436e1cf577744373ffd87b1221d2b88 | |
| ToppCell | BAL-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 7.46e-05 | 199 | 97 | 5 | d39be8b173156bf87baddd3caed4b35597c53ea1 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | eac46978e2b3d38cf42b44f7b0350d0489d036b3 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Alveolar_macrophages|Lung / Manually curated celltypes from each tissue | 7.64e-05 | 200 | 97 | 5 | 3b236900df407bf5a8c44e76d003a7a37d251db6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 9f21e4e0913d8ef95a3f771dff0abaad8fe1d9f2 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.64e-05 | 200 | 97 | 5 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.64e-05 | 200 | 97 | 5 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 7.64e-05 | 200 | 97 | 5 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|Fibroblasts / Location, Cell class and cell subclass | 7.64e-05 | 200 | 97 | 5 | f62833c63f9c6a94b6cc2ba8e2f960e67f093f48 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | 77a68e8fd97a3f3467d25032067fd7ad52ab8522 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 7.64e-05 | 200 | 97 | 5 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Kidney-Tubules|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 7.64e-05 | 200 | 97 | 5 | 0726456906e078244a9cff35aee8c5bce4566fb1 | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 7.64e-05 | 200 | 97 | 5 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | severe-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.64e-05 | 200 | 97 | 5 | d6767f06fe13be8110a86c2a6029be2dd9ce666c | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 116 | 97 | 4 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.29e-04 | 45 | 97 | 3 | 668add3b0e69b851942df9c52850ed2285e08494 | |
| Drug | 3-isoreserpine | 1.13e-07 | 190 | 96 | 9 | CID000005052 | |
| Disease | Adenocarcinoma of large intestine | 1.36e-05 | 96 | 93 | 5 | C1319315 | |
| Disease | Autistic Disorder | 1.94e-05 | 261 | 93 | 7 | C0004352 | |
| Disease | alcohol use disorder measurement | 6.12e-05 | 214 | 93 | 6 | EFO_0009458 | |
| Disease | Alzheimer's disease (is_implicated_in) | 6.29e-05 | 132 | 93 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | SLC11A2 ABCA12 ABCB5 ABCC5 MSH2 GRIN2A CSMD3 ABCA9 LRP1 SORL1 | 7.46e-05 | 702 | 93 | 10 | C0009402 |
| Disease | phospholipase D3 measurement | 1.46e-04 | 6 | 93 | 2 | EFO_0802866 | |
| Disease | Adult neuronal ceroid lipofuscinosis | 1.46e-04 | 6 | 93 | 2 | cv:C0022797 | |
| Disease | Common Migraine | 2.04e-04 | 7 | 93 | 2 | C0338480 | |
| Disease | Colorectal Neoplasms | 2.50e-04 | 277 | 93 | 6 | C0009404 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 2.72e-04 | 8 | 93 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 2.72e-04 | 8 | 93 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | Neuronal ceroid lipofuscinosis | 3.49e-04 | 9 | 93 | 2 | cv:C0027877 | |
| Disease | alcohol consumption measurement | ACSS1 GRIN2B CSMD3 BIRC6 SLC39A13 CLIP4 NRXN1 ASTN2 IGSF9B FUT2 KIT SORL1 | 5.26e-04 | 1242 | 93 | 12 | EFO_0007878 |
| Disease | Semantic-Pragmatic Disorder | 5.31e-04 | 11 | 93 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 5.31e-04 | 11 | 93 | 2 | C0751257 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 5.31e-04 | 11 | 93 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | Pancreatic Ductal Adenocarcinoma | 5.31e-04 | 11 | 93 | 2 | C1335302 | |
| Disease | Language Delay | 5.31e-04 | 11 | 93 | 2 | C0023012 | |
| Disease | Language Development Disorders | 5.31e-04 | 11 | 93 | 2 | C0023014 | |
| Disease | vascular dementia (is_marker_for) | 5.31e-04 | 11 | 93 | 2 | DOID:8725 (is_marker_for) | |
| Disease | Speech Delay | 5.31e-04 | 11 | 93 | 2 | C0241210 | |
| Disease | hypertension (is_implicated_in) | 5.93e-04 | 121 | 93 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | X-11444 measurement | 7.49e-04 | 13 | 93 | 2 | EFO_0021237 | |
| Disease | Bipolar Disorder | 7.91e-04 | 477 | 93 | 7 | C0005586 | |
| Disease | bitter alcoholic beverage consumption measurement | 8.45e-04 | 133 | 93 | 4 | EFO_0010092 | |
| Disease | ceramide measurement | 9.03e-04 | 235 | 93 | 5 | EFO_0010222 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.15e-03 | 16 | 93 | 2 | C0751885 | |
| Disease | migraine without aura, susceptibility to, 4 | 1.15e-03 | 16 | 93 | 2 | MONDO_0011847 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.30e-03 | 17 | 93 | 2 | C0751883 | |
| Disease | family history of Alzheimer’s disease | 1.48e-03 | 71 | 93 | 3 | EFO_0009268 | |
| Disease | Alcoholic Intoxication, Chronic | 1.61e-03 | 268 | 93 | 5 | C0001973 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.62e-03 | 19 | 93 | 2 | C0751884 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 1.74e-03 | 75 | 93 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | visual cortical surface area measurement | 1.80e-03 | 20 | 93 | 2 | EFO_0004771 | |
| Disease | Schizophrenia | 1.89e-03 | 883 | 93 | 9 | C0036341 | |
| Disease | schizophrenia (is_implicated_in) | 1.94e-03 | 78 | 93 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | Antimigraine preparation use measurement | 1.98e-03 | 21 | 93 | 2 | EFO_0009939 | |
| Disease | aspartate aminotransferase measurement | 2.21e-03 | 904 | 93 | 9 | EFO_0004736 | |
| Disease | Huntington's disease (is_implicated_in) | 2.38e-03 | 23 | 93 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | mean corpuscular hemoglobin concentration | SLC17A2 SLC11A2 HECTD4 ABCC5 HNRNPUL1 ABCA7 WDHD1 SLC5A6 SLC23A2 GAA | 2.53e-03 | 1105 | 93 | 10 | EFO_0004528 |
| Disease | migraine disorder, Headache | 2.57e-03 | 86 | 93 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | Myasthenic Syndromes, Congenital | 2.59e-03 | 24 | 93 | 2 | C0751882 | |
| Disease | cholelithiasis | 2.74e-03 | 88 | 93 | 3 | EFO_0004799 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 2.74e-03 | 88 | 93 | 3 | EFO_0803332 | |
| Disease | response to TNF antagonist, joint damage measurement | 2.81e-03 | 25 | 93 | 2 | EFO_0004653, EFO_0005413 | |
| Disease | Depressive Symptoms | 3.04e-03 | 26 | 93 | 2 | C0086132 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IDFSGPTIYGWAVLA | 131 | Q9Y277 | |
| YAAAGFPAWEVYLRA | 301 | Q17RC7 | |
| YGFVYWLPPAIFRSS | 136 | Q07001 | |
| VWIGYVSSGVNPLVY | 366 | P41595 | |
| DIGWITGHSYVVYGP | 336 | Q9NUB1 | |
| RLLNTAGGYPYSFWI | 681 | P78357 | |
| YLGGAPSAYWLVRAT | 511 | Q63HQ2 | |
| AATTGGSVYWYFVLL | 1441 | Q9NR09 | |
| WGFSISYICSPGYEL | 3251 | Q7Z407 | |
| LRISGLYPSAYWFGQ | 1056 | Q8IUA7 | |
| LYPSAYWFGQALVDV | 1061 | Q8IUA7 | |
| FWYGTSLILNGEPGY | 306 | Q2M3G0 | |
| LIAWYVRNVFPGTYG | 1266 | Q86UK0 | |
| IVWISFIPAYASTYG | 816 | P41180 | |
| PFSAIFEVLGYWAFG | 81 | P35348 | |
| GSPYVVLFDIGYSAW | 111 | P54840 | |
| TTNFAPGYWYGIELE | 506 | Q8N3C7 | |
| WPYTTLERGYDLVTG | 561 | O75129 | |
| PSYRGFLIFWGYIIV | 381 | O43520 | |
| DPLTDLRYVWGGFVY | 491 | Q8IZY2 | |
| SQGFPIEGWAVVYYI | 321 | Q5VW38 | |
| PDYGYGWFHTSLILE | 126 | P14920 | |
| ISETLGWPFVFYIFG | 146 | O00476 | |
| GVLLWEVFSYGRAPY | 411 | P42679 | |
| VYGTNPLEFEFLWGS | 241 | Q8TD90 | |
| GIFLWELFSLGSSPY | 856 | P10721 | |
| PFAVTLYGGEVYWTD | 1481 | Q07954 | |
| SFYYGTFPLGFSWGV | 31 | Q6UWM7 | |
| PIYVILVGGWSFSLY | 216 | O14524 | |
| FVLWEVGYPLYIYGS | 6 | Q6ZU69 | |
| FVLWDVGYPLYTYGS | 6 | A6NFA0 | |
| YFGPAALYIWAVGIL | 366 | P49281 | |
| VFPTEVWTALLNYGY | 626 | Q9ULB1 | |
| APSFYWEIEIVSYGD | 1991 | Q9Y4D8 | |
| FFGWSAYVPEGLLTS | 206 | Q9UHM6 | |
| VPWSVYGVYIQAAGG | 841 | O15440 | |
| GGSVEIPFSFYYPWE | 46 | Q9UKJ1 | |
| TAYEWVNPAAYGLVV | 1086 | Q9ULT8 | |
| AAFNYWHPEIVYSGG | 201 | Q9BTV6 | |
| VGAAVGTFAWYLTYG | 251 | A5D6W6 | |
| YFFELGTYDPGLDVW | 681 | Q7Z7M9 | |
| YYLFAWGPAIQGSIT | 226 | Q9P0K9 | |
| FGIWAAYLTGGDTIY | 291 | Q10981 | |
| PLWILGDVFIGRYYT | 381 | P07339 | |
| FGYGSLVWRPDFAYS | 36 | Q9BUX1 | |
| LGVKYAVFSTGLWYP | 151 | Q16880 | |
| AVFSTGLWYPAEVGA | 156 | Q16880 | |
| IVSFGYSLYAGWIGA | 151 | O75508 | |
| GPGVYSNVSYFVEWI | 1016 | Q9Y5Q5 | |
| AEVTGYFPLGTWYDL | 761 | P10253 | |
| GYPFWGALIFILTGY | 81 | Q96JA4 | |
| WAVFPNYFGGSELVV | 491 | Q6UXX5 | |
| PSKFHGYAYDGIWVI | 351 | O75899 | |
| YGVLIFIYGWPFLQT | 21 | Q4VXA5 | |
| GGLFTYVLFWTFLYG | 91 | Q9BV81 | |
| GLPGLVVAGYSYWTL | 461 | Q5T4B2 | |
| TGTAPGLLLFFYFWA | 256 | Q9Y226 | |
| ETQGWILGSFFYGYI | 106 | Q9NRA2 | |
| TAAWVLPFTSGGFLY | 316 | Q96H72 | |
| VFRPGLGWYTVNSAY | 21 | Q13740 | |
| ATPEWAALLYYGPFI | 121 | Q6NUT3 | |
| YGPFIVIFQFGWAST | 131 | Q6NUT3 | |
| TYDGFGLAWAISEYI | 756 | P43246 | |
| YWPSDGLVSYGDITV | 646 | P18433 | |
| GYPLTIEGFAYLWSG | 231 | Q9BUJ2 | |
| TAEAVYVPGYGLAWA | 71 | Q9GZV3 | |
| TWTGPRNVVYGIFYA | 1861 | Q92673 | |
| IRAYATVIDGPEYFW | 1521 | O60522 | |
| SWGYGCTLRDFPGVY | 281 | A6NIE9 | |
| LTLAYAFEPRGWVFG | 116 | P49683 | |
| SVLWPYYVLGFGIFL | 146 | P0DP42 | |
| WILPLTYSGAVFYTG | 156 | Q969N4 | |
| FPGVTSVWALFIYGT | 41 | Q8NBD8 | |
| FVGYFPATVLWELLG | 206 | Q9HCE1 | |
| FDDSEYWVLGPTRYS | 181 | O75900 | |
| LGVPSEIYRFGTQYW | 86 | Q9Y289 | |
| VAWYPGFTFLLSAGL | 411 | Q7Z3Q1 | |
| VLWEVFSYGLQPYCG | 681 | Q01974 | |
| TFIYPDGSRYEGEWA | 81 | Q8WYR4 | |
| TPEVRAGYLGYTVTW | 396 | P20701 | |
| PSGLYYWYLVTEGQI | 216 | Q9NWW5 | |
| VLWEIFSFGLQPYYG | 681 | Q01973 | |
| AFFDSIVGVAAYVGW | 596 | Q99570 | |
| IPGDTAWLLYDTYGF | 406 | P49588 | |
| FSYLPISPTFVGYTW | 616 | Q9UGH3 | |
| YFTVLPGWEYRQEAG | 421 | Q9UPX0 | |
| VIAYFSRAGLPSWQY | 426 | A6NKU9 | |
| YLAWIGFSAEGTPCY | 626 | O75717 | |
| YGRVGWFPANYVEED | 826 | P15498 | |
| YVGLTDFKPGYWIGV | 181 | Q99426 | |
| ALSWPFIFYIFGSTG | 206 | O00624 | |
| YPDGWYTDIRFSLGV | 136 | P31213 | |
| PNYTYEVGSWIGFAI | 246 | Q9NZ01 | |
| FDGGYLQRFSVWYTP | 531 | Q9P2J2 | |
| WYPYGIAQVSFADLL | 106 | Q6ZUG5 | |
| GGSVEIPFSFYYPWE | 46 | Q9UKJ0 | |
| VGSFYIPGGYFSSVW | 146 | Q13530 | |
| LFLATFFPTWEGGIY | 51 | Q9BVK8 | |
| LYEWRNYGPGFIDST | 251 | Q9BUY5 | |
| PDGSFTNIWFYFGVV | 151 | Q96SA4 | |
| VAQLFGGSYIYHWDP | 296 | Q8N145 | |
| LGLTGYDFFWIVPSL | 246 | Q12879 | |
| GYGYTWIVPSLVAGD | 251 | Q13224 |